Alignment Healthcare (NASDAQ:ALHC) CEO John Kao Sells 180,000 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John Kao sold 180,000 shares of the business’s stock in a transaction that occurred on Tuesday, March 10th. The shares were sold at an average price of $18.19, for a total value of $3,274,200.00. Following the completion of the sale, the chief executive officer owned 2,472,641 shares of the company’s stock, valued at $44,977,339.79. This trade represents a 6.79% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Alignment Healthcare Stock Performance

Shares of ALHC opened at $18.10 on Wednesday. The business’s fifty day moving average price is $20.91 and its 200 day moving average price is $18.73. Alignment Healthcare, Inc. has a 12-month low of $11.63 and a 12-month high of $23.87. The stock has a market capitalization of $3.70 billion, a PE ratio of -1,808.19, a price-to-earnings-growth ratio of 2.67 and a beta of 1.18. The company has a debt-to-equity ratio of 1.80, a current ratio of 1.71 and a quick ratio of 1.71.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.10. Alignment Healthcare had a negative net margin of 0.02% and a negative return on equity of 0.49%. The firm had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1 billion. During the same quarter in the previous year, the firm earned ($0.16) earnings per share. The firm’s revenue for the quarter was up 44.4% compared to the same quarter last year. Equities research analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have commented on the company. Wall Street Zen downgraded Alignment Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday. KeyCorp reiterated an “overweight” rating and set a $28.00 price target on shares of Alignment Healthcare in a research report on Thursday, January 22nd. JPMorgan Chase & Co. raised their price target on Alignment Healthcare from $23.00 to $26.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Robert W. Baird set a $28.00 price objective on Alignment Healthcare in a research report on Friday, January 30th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday, January 21st. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $24.56.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of ALHC. Wellington Management Group LLP raised its stake in shares of Alignment Healthcare by 167.3% during the third quarter. Wellington Management Group LLP now owns 11,089,727 shares of the company’s stock valued at $193,516,000 after purchasing an additional 6,940,277 shares in the last quarter. Invesco Ltd. increased its stake in Alignment Healthcare by 122.3% during the 2nd quarter. Invesco Ltd. now owns 4,170,529 shares of the company’s stock valued at $58,387,000 after buying an additional 2,294,739 shares during the period. Capital World Investors bought a new stake in shares of Alignment Healthcare during the 4th quarter worth about $44,203,000. Loomis Sayles & Co. L P acquired a new stake in shares of Alignment Healthcare in the 4th quarter worth approximately $44,162,000. Finally, Danica Pension Livsforsikringsaktieselskab bought a new position in shares of Alignment Healthcare in the fourth quarter valued at approximately $39,500,000. 86.19% of the stock is owned by institutional investors and hedge funds.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.